Upcoming FDA Meetings

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Upcoming FDA Meetings

Email Not Looking Beautiful? View it in your browser.

	December 10, 2012 http://www.fda.gov/womens   Upcoming FDA Meetings Drug Safety and Risk Management Advisory Committee Meeting December 12-13, 2012       UPDATED PUBLIC PARTICIPATION INFORMATION The procedure portion has been updated to an open public hearing from approximately 1:15 p.m. to 1:45 p.m. on December 12 and an open public hearing from approximately 11 a.m. to 11:30 a.m. on December 13.       On December 12, 2012, the committee will meet to discuss the various strategies used by the Agency to define and address teratogenic risk, including requiring REMS with ETASU. On December 13, 2012 the committee will discuss two common risk management tools used to minimize the risk of teratogens – contraception and pregnancy testing.       Meeting Information **************************************** Public Meeting on Pharmacy Compounding December 19, 2012   The FDA will hold a public meeting entitled "Framework for Pharmacy Compounding: State and Federal Roles."  At this public meeting, FDA and State representatives will share their perspectives.   Meeting Information  Please share this update with your network, members, constituents, and community.  FDA Office of Women’s Health 10903 New Hampshire Avenue WO32 - Room 2333 Silver Spring, MD 20993-0002 301-796-9440

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420